On February 24, Baudax Bio Inc. (BXRX) announced the pricing of a $10.0 million public offering. Following this, the stock plunged deep in the premarket
On January 20, shares of Baudax Bio Inc. (BXRX) skyrocketed in the premarket session to reach $0.27 at the last check. No official news from
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.